Abstract Background and Aims AKI is a public health problem, affecting one in every five hospitalized adults. It's incidence in the ICU fluctuates between 16-36%, with a mortality rate between 28%-50%. The need for HD in the ICU varies from 3-7%, and these patients have twice the risk of death. But few studies have compared patients in medical (MD-ICU) and surgical (Qx-ICU) critical care units. Method We conducted a single center, retrospective study of individuals admitted to ICU units that underwent nephrology consultation. We examined a 5-y period, in the pre-COVID era, we excluded the pandemic period, because COVID patients were admitted to MD- and Qx-ICU indistinctly. We compared epidemiological and clinical characteristics and hard outcomes between patients in both groups. Results We included 433 patients, 42% in the MD-ICU. We found no statistical differences between sex, HTN, DM, Charlson's-Index, and previous CKD. Qx-ICU patients were older, suffered less Coronary Artery (CAD), and Cerebrovascular Disease (CVD), and their AKI etiology was more frequently obstructive. MD-ICU individuals showed less hospital acquired AKI, and were more frequently classified in KDIGO Stage 3, (Fig. A, Features). We found no differences in time to nephrology consultation, length of hospital-stay and in-hospital mortality. Qx-ICU patients had shorter ICU stay, needed less frequently acute HD, and were less HD dependent at discharge (Fig. B, Results). In-hospital mortality for patients that needed HD in MD-ICU OR 2.2 (1.2-4.1, P = 0.12), Qx-ICU OR 4.4 (2.2-8.6, P < 0.001). Conclusion Individuals don't differ remarkably in their baseline clinical characteristics (Charlson`s, DM, CKD). Nevertheless, Qx-ICU patients are older, suffer less CAD, and CVD, and show significantly more hospital acquired AKI. We found that medical ICU patients suffered worst AKI stage, longer ICU stay, required acute HD and were HD dependent more frequently, but had a lower risk of death when needing acute HD. We found no differences in general mortality rate, and general hospital stay, and time to nephrology consultation between groups. We need multicentric and well-powered studies to explore these differences more profoundly, find clusters of patients and phenotypes of AKI and discover protective factors and new preventive measures against hospital acquired AKI, and need for acute HD.
Read full abstract